MCC Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of MCC Antibodies for investigating the role of MCC protein. MCC Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MCC, or Mutated in Colorectal Cancers, is a critical protein involved in cell cycle regulation and apoptosis. Its dysregulation has been implicated in the development of colorectal cancer, making it a significant target for cancer research. Understanding MCC function is essential for elucidating the mechanisms of tumorigenesis and developing potential therapeutic strategies. Research into MCC protein can reveal crucial insights about cell cycle control and its relationship to cancer development. Investigating MCC expression patterns helps identify its role in various cellular pathways and signaling mechanisms. Detailed analysis of MCC interactions with other proteins provides valuable information about cancer progression and potential treatment approaches. Santa Cruz Biotechnology monoclonal antibodies for MCC research support scientists worldwide in advancing our understanding of cancer biology and developing new therapeutic strategies.